SMi Groups' 4th annual BioBanking conference returns to London this June

1. BOOK BYARY
RU
28TH FEB
0
‘Topics were interesting and informative’ Novartis
SAVE £30
Y
BOOK B H
RC
31ST MA
0
SAVE £10
SMi presents their 4th annual...
23 - 24
Biobanking
JUNE
2014
Holiday Inn Regents Park Hotel, London, UK
NEW FOR 2014
KEY SPEAKERS
• Key panel discussion on best
strategies for use of samples
with Novartis and Sanofi
• Hear regulatory insight from EC
and INSERM on data
management
• Explore how to further enhance
sample quality to drive forward
medical research
• Evaluate the importance of
networks to improve your
organisation processes
• Exclusive case study from
AstraZeneca on the Biobank
Application (ABBA)
• Dr Mads Røpke, Senior Scientific Officer, LEO Pharma
• Dr Anne Bahr, R&D Privacy Officer, Sanofi
• Mr Steve Kelly, Team Leader, Discovery Sciences (Biobank),
AstraZeneca
• Paul Whittaker, Unit Head for Pre-clinical Biomarkers, Novartis
• Arndt Schmitz, Senior Scientist, Global Biomarker Research, Bayer
• Professor Berthold Huppertz, Director, CEO, Biobank Graz
• Dr Kirstin Goldring, UCL Biobank and NIHR BioResource Senior
Co-Ordinator, University College London
• Mr Octavi Quintana-Trias, Director for the European Research
Area, European Commission
• Dr Giuseppina Bonizzi, Biobank and Biomolecular Resource
Infrastructure Co-ordinator, European Institute of Oncology
• Dr Javier Arias Díaz, Co-ordinator of the Council of Europe
Bioethics Committee on Biobanks, Council of Europe
PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPS
25th June 2014, Holiday Inn Regents Park Hotel, London, UK
Ethics and Research in Biobanking
Biobanking - start small and grow
Hosted by Dr Ann Cooreman, COO, Tissue Solutions
Hosted by Neil Benn, Managing Director, Ziath
8.30am - 12.15pm
1.00pm - 5.30pm
www.bio-banking-event.com
BOOK BY 28TH FEBRUARY AND SAVE £300 / BOOK BY 31ST MARCH AND SAVE £100
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711

2. Biobanking 2014
www.bio-banking-event.com
Day One | Monday 23rd June 2014
8.30
Registration & Coffee
1.40
9.00
Chairman's Opening Remarks
Dr Brian Thomson, Director, Nottingham Health Science Biobank
EXPLORING THE VALUE OF BIOSAMPLES
9.10
KEYNOTE ADDRESS
Maximising the value of biosamples
• Measuring the value of the biosample
• Ensuring sustainability of sample collection
• Adding value to the biosample: clinical and pathological
annotation
• Biosamples as part of the electronic health record
Dr Brian Thomson, Director, Nottingham Health Science Biobank
The importance, practicalities and challenges of Brain
banking
• CNS tissue banking in the UK
• The importance of tissue banking in CNS research
• Challenges associated with Brain Banking
• Looking to the future
Dr Claire Troakes, Brain Bank Co-ordinator, London
Neurodegenerative Diseases Brain Bank, Institute of
Psychiatry, King’s College London
MAXIMISING THE POWER OF BIOBANKS
2.20
Further enabling sample quality for future research
• Exploring technology as an advantage
• Mitigating the risks of bad storage of samples
• Emerging issues in sample quality strategically
• Harmonization of sample quality in biobank networks
Professor Berthold Huppertz, Director and CEO, Biobank Graz
The AstraZeneca Biobank Application (ABBA)
• Highly detailed level of sample tracking
• Standardised sample characterisation data across clinical
studies
• Improved visibility of sample catalogue
• Improved governance over samples
Steve Kelly, Team Leader, Discovery Sciences (Biobank),
AstraZeneca
3.00
Afternoon Tea
10.30
Morning Coffee
3.30
11.00
Case study: Establishing a repository for patient samples from
clinical studies
• Creating biobanking structures to enable future research
on clinical patient samples
• Implementing framework for combining molecular
profiling of samples with patient metadata
• Evaluating practical, legal and regulatory implications
• An industry perspective
Dr Mads Røpke, Senior Scientific Advisor, LEO Pharma
Supporting Biobanks and BioResources at UCL
• Diversity of biobanking requirements in academia
• A biobanking model to support academics
• Tissue access for patient benefit
• A national approach to BioResources
Dr Kirstin Goldring, UCL Biobank and NIHR BioResource Senior
Co-Ordinator, University College London
9.50
11.40
Challenges in reusing samples: developing an effective
consent form
• Introduction to EU Personal Data Protection principles and
their application to Human Biological Samples
• Coding, withdrawl and re-using of personal data and
biological samples
• What should be included in the Informed Consent form?
• Last updates regarding the new EU Data Protection
regulation draft
Dr Anne Bahr, R&D Privacy Officer, Sanofi
12.20
Networking Lunch
4.10
4.50
Moving from clinical sample to laboratory measurement:
automating epidemiological research
• Highlight the challenges associated with accessing and
measuring clinical samples for large scale epidemiology
research
• Use of automation for efficiently accessing and preparing
samples for measurement
• Case studies for projects producing genetic and clinical
biochemistry research measurements from thousands of
samples
• Methods for controlling measurement error and
maximising research application
Matt Sims, Head of Research Operations, MRC Epidemiology,
University of Cambridge
Chairman's Closing Remarks and Close of Day One
Register online at: www.bio-banking-event.com • Alternatively fax
Who should attend?
SPONSORSHIP AND
EXHIBITION OPPORTUNITIES
Heads of Department, Directors, Managers, Team Leaders of:
• Biobanking
• Biorepository
• Biological Sample
Management
• Biosample Management
• Pharmacogenomics
• Pathology
• Genomics
• Personalised Medicine
•
•
•
•
•
•
Translational Medicine
Lab Management
Inventory Management
Molecular Technologies
Biologics Research Data
Privacy / Protection / Security
Officers
• Quality Control and Quality
Management
•
•
•
•
•
•
•
•
Research and Development
Supply Chain
Population based biobanks
Disease based biobanks
Hospital Trusts
Research Institutes
Tecnology Transfer
Bioinnovation
SMi offer sponsorship, exhibition, advertising
and branding packages, uniquely tailored to
complement your company’s marketing
strategy. Prime networking opportunities exist
to entertain, enhance and expand your client
base within the context of an independent
discussion specific to your industry.
Should you wish to join the increasing number
of companies benefiting from sponsoring our
conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or
email: amalick@smi-online.co.uk

3. www.bio-banking-event.com
8.30
• Audiovisual materials have been prepared to inform
patients and to facilitate the work of our research nurse
• IBBRI is integrated with the Department of Pathology
• A highly integrated software system allows to manage all
aspects of biobanked samples
Dr Giuseppina Bonizzi, Biobank and Biomolecular Resource
Infrastructure (IBBRI) Co-ordinator, European Institute of
Oncology, Milan, Italy
Registration & Coffee
9.00
Day Two | Tuesday 24th June 2014
Chairman's Opening Remarks
Dr Brian Thomson, Director, Nottingham Health Science Biobank
SPOTLIGHT ON REGULATION AND ETHICS
9.10
9.50
10.30
KEYNOTE ADDRESS
Impact of the new Data Protection regulation on biobanking
• Assessing the forthcoming regulation in the context of biobanks
• Participants protection in research biobanking, new rights
from the Data Protection regulation
• Impact of the forthcoming regulation on research
biobanking in the light of European infrastructures
• Impact of the forthcoming regulation on the industry and
academia partnerships
Dr Emmanuelle Rial-Sebbag, Permanent Research Fellow,
Institut
Ethics in biobanking – a CoE perspective
• Ethical principles at stake
• The dilemma of informed consent
• The importance of a good policy
• Building trust
Dr Javier Arias Díaz, Co-ordinator of the Council of Europe
Bioethics Committee on Biobanks, Council of Europe
Morning Coffee
2.20
Biobanking to support large-scale research
• Large-scale research often involves the collection and
storage of tens of thousands of human samples from
around the world and samples may be stored for
decades prior to use. This can create a unique set of
challenges to provide suitable sample collection,
processing, transport and storage
• Assay requirements may differ between projects; from
simple biomarker investigations up to ‘Omic’ studies and
involve a few thousand samples up to several hundred
thousand. Biobanking solutions need to be flexible to
meet changing demands in biomarker analysis
• The experience of CTSU and UK Biobank - sample stability
studies are paramount to support the utility of large-scale
biobanks
Dr Mike Hill, Laboratory Director, CTSU Wolfson Laboratories,
Nuffield Department of Population Health, University of Oxford
3.00
Afternoon Tea
3.20
Research biobanking in a pharmaceutical industry setting
• Rationale for biobanking in biomarker research and
validation
• Experiences with the IMI: collaborations
• Discussion of European oncology case studies
Arndt Schmitz, Senior Scientist, Global Biomarker Research, Bayer
4.00
Panel discussion: strategies for sample usage
• Challenges of using samples commercially
• Evaluating the validity of using samples
• Managing samples accurately throughout the chain
• Ethical approval and regulatory compliance
Paul Whittaker, Unit Head for Pre-Clinical Biomarkers, Novartis
Dr Anne Bahr, R&D Privacy Officer, Sanofi
Amir Gander, Senior Knowledge Transfer Associate, University
College London
4.40
From bedside to research laboratory: challenges to get
appropriate samples and data for biomarker research and
development projects
• Retrospective, prospective and combined study designs:
the need for banked samples and options for prospective
collections
• About ivory towers: researchers and clinicians should
discuss biomarkers studies as early as possible
• Don’t expect a one-fits-all solution: the challenge to work
within decentralised regulative and ethical environments
• Sample/data quality starts even before collection: the
need to understand collection logistics at clinical sites
• More about quality: SOPs, useful lab tests and monitoring
Dr Michael Jürgens, Managing Director, AdeptBio UG
5.20
Chairman’s Closing Remarks and Close of Day Two
DIVERSE INSIGHTS INTO BIOBANKING
11.00
11.40
12.20
Research infrastructures in biobanking
• The EU policies for research infrastructures
• The case of biobanks
• The new BBMRI-ERIC
• Perspectives under Horizon 2020
Mr Octavi Quintana, Director, Directorate General of
Research and Innovation, European Commission
The UK ME/CFS Biobank experience
• Patient oriented resource building
• Infrastructure for data and sample gathering
• Open access for academics and industry
• Sustainability of a disease specific biobank
Dr Luis Nacul, Principal Investigator, Clinical Research Department,
London School of Hygiene and Tropical Medicine
Networking Lunch
BIOBANKING WITHIN THE ERA OF PERSONALISED MEDICINE
1.40
Biobanking and everything around: a case study
presentation from European Institute of Oncology (IEO)
• The IEO Biobank and Biomolecular Infrastructure (IBBRI) is
an institutional infrastructure within the Molecular
Medicine Program (MMP) of IEO
• Collecting and storing biological specimens from patients
through specifically designed informed consent
x your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
Want to know how you
can get involved?
Interested in promoting your
services to this market?
Contact Humaira Kaiser,
SMi Marketing on
+44 (0) 20 7827 6197, or
email: hkaiser@smi-online.co.uk
Supported by

4. POST-CONFERENCE WORKSHOP A
Wednesday 25th June 2014
8.30am - 12.15pm
Holiday Inn Regents Park Hotel, London, UK
Ethics and Research in Biobanking
Hosted by
Dr Ann Cooreman, COO, Tissue Solutions
Overview of workshop:
The workshop will give delegates a comprehensive
overview of ethics and research with biological
samples in the UK.
Why you should attend?
• You work with biosamples for drug development,
diagnostics development, toxicology studies etc.
• You would like to find out more about ethics
• You want to gain an understanding about the
ethical principles underlying governance in the UK
and why they are so important
• You would like to know about the legal and
regulatory requirements in the UK for using human
biomaterials in research
Programme:
8.30
Registration and Coffee
9.00
Welcome and Introduction
9.15
Definition and discussion of the current Ethics
Regulations for Research in Pharma and
Biotech in the UK
• Who needs Ethics?
• HTA and Research
• NRES and Research
• HTA vs. Research
• Ethics Application: what you need to
know
10.30
Coffee break
10.45
Research Tissue Banks: what are they? How
do they work
• Virtual Tissue Banks: what are they, how do
they work
• Practical exercise: Pros and Cons of virtual
Biobanking
• Best working practices (national and
international)
11.45
Importing Biosamples
• Ethics and governance
12.15
General Round Discussion & Close
About the workshop host:
Dr. Ann Cooreman is a multi career woman.
She spent the first 15 years of her working life
in academic research and teaching as a
linguist. This was followed by a 4 year stint
working as Project Manager at IBM. In 2001
she became the Tissue Acquisitionist and Ethics
coordinator for a small Biotech company in Glasgow.
This eventually led to the founding of Tissue Solutions in
2007 with colleague Dr.Morag MacFarlane. Ann has
extensive experience in gaining ethics permission and
preparing the associated protocols for prospective
collections. Ann has also worked in a business
development role and has successfully managed
several collaborative tissue based research programs
with clients worldwide.
About Tissue Solutions:
Tissue Solutions is a virtual Biobank,
offering a single point of access to
an entire range of human biological
materials, including diseased and
normal human tissues in fresh, frozen and FFPE
formats, and body fluids (e.g. blood, serum, plasma,
CSF, ascites, urine, sputum, and synovial fluid). Using
our large network of sources we find the tissues
researchers require for drug discovery and
development such as genomics, proteomics,
biomarker studies, antibody testing, pharmacology
and toxicology studies.
For more information about
www.tissue-solutions.com
the
company:

5. POST-CONFERENCE WORKSHOP B
Wednesday 25th June 2014
1.00pm - 5.30pm
Holiday Inn Regents Park Hotel, London, UK
Biobanking – start small and grow
Hosted by
Neil Benn, Managing Director, Ziath
Overview of workshop:
Biobanking is often thought of as millions of tubes
in a highly automated facility which is the image
that often hits the headlines. However often a
biobank is much more moderate in number; and
budget! Therefore this workshop will run through
the basic measures needed to setup a biobank
taking into account handling samples in an
efficient and secure manner and also detailing
the potential paths of upgrading as the number of
samples and complexity of the processing of
these samples grows.
Why you should attend
• Looking to set up a new Biobank
• Looking to manage samples on a budget
• Curious about new technologies
• Looking to make efficiencies in your existing
biobank
Programme:
1.00
Registration and coffee
1.30
Introduction and outline
2.00
What is a biobank?
2.30
Coffee break
2.45
Storage issues
3.00
Informatics issues in biobanking including
practical demonstrations
3.30
Sample and data security
4.00
Scaling your biobank up
- Things to consider
4.30
Biobank case studies
5.00
Q&A session
5.30
Close of workshop
About the workshop host:
Neil Benn is the Managing Director of Ziath Ltd, a
company dedicated to sample management;
previous to this Neil held roles in academia and
industry in organisations such as the Max Planck
society and GSK. Neil holds a bachelors in
Biotechnology and a Masters in Computer Science.
About Ziath:
Ziath Ltd is a company
dedicated
to
sample
management; founded and
run by scientists and engineers they design and
provide the tools, expertise and advice needed to
manage your samples in a cost-effective manner.

6. BIOBANKING
Conference: Monday 23rd & Tuesday 24th June 2014, Holiday Inn Regents Park Hotel, London, UK
Workshops: Wednesday 25th June 2014, London
4 WAYS TO REGISTER
www.bio-banking-event.com
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor South,
Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK
EARLY BIRD □
DISCOUNT □
Book by 28th February to receive £300 off the conference price
Book by 31st March to receive £100 off the conference price
CONFERENCE PRICES
Unique Reference Number
Our Reference
LV P-108
DELEGATE DETAILS
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title:
Forename:
Surname:
I would like to attend: (Please tick as appropriate)
□ Conference & 2 Workshops
□ Conference & 1 Workshop
□ Conference only
□ 1 Workshop only
□ 2 Workshops
AM Workshop □ PM Workshop □
Fee
£2697.00
£2098.00
£1499.00
£599.00
£1198.00
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees
£999.00
Job Title:
Department/Division:
Company/Organisation:
+ VAT
+ VAT
+ VAT
+ VAT
+ VAT
Total
£3236.40
£2517.60
£1798.80
£718.80
£1437.60
+ VAT
£1198.80
The conference fee includes refreshments, lunch, conference papers and access
to the Document Portal containing all of the presentations.
Email:
Company VAT Number:
Address:
LIVE STREAMING/ON DEMAND/ DOCUMENTATION
Unable to travel, but would like to watch the conference live, ask questions,
participate as if you were in the room?
Price
Total
Town/City:
Post/Zip Code:
Country:
Direct Tel:
Direct Fax:
□ Live Streaming
□ On demand
Mobile:
(available 24 hours after the event)
□ Access to the conference documentation
Switchboard:
Signature:
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
ACCOUNTS DEPT
Title:
£999.00 + VAT (UK) £1198.80
£599.00 + VAT (UK) £718.80
on the Document Portal
£499.00 + VAT
£499.00 (or only £300 if ordered with the Document Portal)
□ The Conference Presentations - paper copy
£598.80
£499.00
Forename:
Surname:
PAYMENT
Email:
Payment must be made to SMi Group Ltd, and received before the event, by one of
the following methods quoting reference P-108 and the delegate’s name. Bookings
made within 7 days of the event require payment on booking, methods of payment
are below. Please indicate method of payment:
Address (if different from above):
Town/City:
Post/Zip Code:
Country:
Direct Tel:
□ UK BACS
□ Wire Transfer
Direct Fax:
VENUE Holiday Inn, Regents Park, Carburton Street, London, W1W 5EE
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: hotels@smi-online.co.uk or fax +44 (0) 870 9090 712
Terms and Conditions of Booking
Payment: If payment is not made at the time of booking, then an invoice will be issued and must be
paid immediately and prior to the start of the event. If payment has not been received then credit
card details will be requested and payment taken before entry to the event. Bookings within 7 days
of event require payment on booking. Access to the Document Portal will not be given until payment
has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send a
substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing
that cancellation is made in writing and received at least 28 days prior to the start of the event.
Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we have
to cancel the event for any reason, then we will make a full refund immediately, but disclaim any
further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other
products and services. Unless you tick here □ we may also share your data with third parties offering
complementary products or services. If you have any queries or want to update any of the data that
we hold then please contact our Database Manager databasemanager@smi-online.co.uk or visit
our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the
attached letter.
□ Cheque
□ Credit Card
Sort Code 300009, Account 00936418
Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
Swift (BIC): LOYDGB21013, Account 00936418
IBAN GB48 LOYD 3000 0900 9364 18
We can only accept Sterling cheques drawn on a UK bank.
□ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
□□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Card No:
Cardholder’s Name:
Signature:
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
Card Billing Address (If different from above):
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on live
Streaming, on Demand, Document portal and literature distribution for all UK customers and
for those EU Customers not supplying a registration number for their own country here.
______________________________________________________________________________________________
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk